TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex susceptibility to Genetic Test
At DNA Labs UAE, we offer the TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex susceptibility to Genetic Test at a cost of AED 4400.0.
Test Details
The TRPM7 gene is a gene that provides instructions for making a protein involved in the regulation of various cellular processes, including cell growth, differentiation, and death. Mutations in this gene have been associated with a range of neurological disorders, including amyotrophic lateral sclerosis-parkinsonism/dementia complex (ALS-PDC).
NGS (next-generation sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. This type of testing is particularly useful in cases where there is suspicion of a genetic disorder but the specific gene or genes involved are not known.
NGS genetic testing for the TRPM7 gene can help identify mutations that may be contributing to the development of ALS-PDC. This information can be used to guide treatment and management strategies for affected individuals and their families. However, it is important to note that not all individuals with ALS-PDC will have mutations in the TRPM7 gene, and not all individuals with mutations in this gene will develop ALS-PDC.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to.
Test Name | TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonismdementia complex susceptibility to Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to |
Test Details |
The TRPM7 gene is a gene that provides instructions for making a protein that is involved in the regulation of various cellular processes, including cell growth, differentiation, and death. Mutations in this gene have been associated with a range of neurological disorders, including amyotrophic lateral sclerosis-parkinsonism/dementia complex (ALS-PDC). NGS (next-generation sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. This type of testing is particularly useful in cases where there is suspicion of a genetic disorder but the specific gene or genes involved are not known. NGS genetic testing for the TRPM7 gene can help to identify mutations that may be contributing to the development of ALS-PDC. This information can be used to guide treatment and management strategies for affected individuals and their families. However, it is important to note that not all individuals with ALS-PDC will have mutations in the TRPM7 gene, and not all individuals with mutations in this gene will develop ALS-PDC. |